Topical ABT-263 effectively reduced several senescence markers in aged skin, preparing it for improved wound healing.
Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results